0001564590-21-023357.txt : 20210504 0001564590-21-023357.hdr.sgml : 20210504 20210504161801 ACCESSION NUMBER: 0001564590-21-023357 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210504 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210504 DATE AS OF CHANGE: 20210504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Benefitfocus, Inc. CENTRAL INDEX KEY: 0001576169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 462346314 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36061 FILM NUMBER: 21888723 BUSINESS ADDRESS: STREET 1: 100 BENEFITFOCUS WAY CITY: CHARLESTON STATE: SC ZIP: 29492 BUSINESS PHONE: 843-849-7476 MAIL ADDRESS: STREET 1: 100 BENEFITFOCUS WAY CITY: CHARLESTON STATE: SC ZIP: 29492 FORMER COMPANY: FORMER CONFORMED NAME: Benefitfocus,Inc. DATE OF NAME CHANGE: 20130507 8-K 1 bnft-8k_20210504.htm 8-K bnft-8k_20210504.htm
false 0001576169 0001576169 2021-05-04 2021-05-04

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) May 4, 2021

 

BENEFITFOCUS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

(State or other jurisdiction of incorporation)

 

 

 

 

001-36061

 

46-2346314

(Commission File Number)

 

(IRS Employer Identification No.)

100 Benefitfocus Way, Charleston, South Carolina 29492

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code (843) 849-7476

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.001 Par Value

 

BNFT

 

Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this Chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this Chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


 

Item 2.02.   Results of Operations and Financial Condition.

On May 4, 2021, Benefitfocus, Inc. issued a press release announcing its operating results for the quarter ended March 31, 2021.  A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.

The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01.   Financial Statements and Exhibits.

(d)   Exhibits

         Exhibit No.     Description                                  

          99.1                Press release dated May 4, 2021

          104                 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

BENEFITFOCUS, INC.

 

 

 

Date: May 4, 2021

 

/s/ Alpana Wegner

 

 

Alpana Wegner

 

 

Chief Financial Officer

(Principal financial and accounting officer)

 

 EX-99.1 2 bnft-ex991_21.htm EX-99.1 bnft-ex991_21.htm

 

Exhibit 99.1

Benefitfocus, Inc.

843-981-8898

pr@benefitfocus.com

 

Investor Relations:

Patti Leahy

843-981-8899

ir@benefitfocus.com   

 

 

 

 

Benefitfocus Announces First Quarter 2021 Financial Results 

 

Exceeds all first quarter guidance metrics

 

Strengthened board independence, diversity and corporate governance

 

 

Charleston, S.C. – May 4, 2021 – Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading  benefits technology platform that simplifies benefits administration for employers, health plans and brokers, today announces its first quarter 2021 financial results.  

 

First quarter highlights include:  

 

•

Exceeded all first quarter 2021 guidance metrics including revenue, adjusted EBITDA and non-GAAP EPS

 

•

Revenue of $65.1 million vs. $66.2 million in first quarter 2020

 

•

Adjusted EBITDA of $14.8 million, up 261% year over year

 

•

Adjusted EBITDA margin of 22.7% up from 6.2% in first quarter 2020

 

•

GAAP EPS of ($0.11) vs. ($0.34) in first quarter 2020

 

•

Non-GAAP EPS of $0.01 vs ($0.21) in first quarter 2020

 

•

Strengthened corporate governance and continued to enhance independence and diversity of board through addition of Coretha Rushing

 

•

Issued State of Employee Benefits™ 2021 Report leveraging unique data capabilities and highlighting importance of benefits to diverse workforce

 

•

Benefitfocus' Health Insights honored for "Best Advance in HR Predictive Analytics Technology" by Brandon Hall

 

“Our first quarter results demonstrate that successful execution around our core enrollment platform is creating a stronger foundation for our business and is leading to improved results,” said Steve Swad, president and chief executive officer of Benefitfocus. “Commercial traction with our employer customers is pacing well as demonstrated by some key wins in the quarter including a global software company and one of the nation's largest convenience stores. Software revenue retention has also improved as we continue to make delivering excellence for our customers job number one”.

 

“We are pleased to report results that exceeded all first quarter guidance metrics,” said Alpana Wegner, chief financial officer. “Our focus on operational excellence is resulting in continued free cash flow and margin expansion. Our second quarter selling season is also off to a good start, which is a key driver for our return to growth next year.”

 

First Quarter 2021 Financial Highlights

Revenue

 

•

Total revenue was $65.1 million, down 2% compared to the first quarter of 2020.

 

 

 

•

Software services was $53.3 million, 3% higher compared to the first quarter of 2020. Software services is comprised of subscription and platform revenue.

 

o

Subscription revenue was $45.5 million, a decrease of 1% compared to the first quarter of 2020.

 

o

Platform revenue was $7.8 million, an increase of 29% compared to the first quarter of 2020.

 

•

Professional services revenue was $11.7 million, down 17% compared to the first quarter of 2020.

Net Loss

 

•

GAAP net loss was ($2.1) million, compared to ($11.1) million in the first quarter of 2020. GAAP net loss per share was ($0.11), based on ($3.7) million net loss available to common stockholders and 32.5 million basic and diluted weighted average common shares outstanding, compared to ($0.34) for the first quarter of 2020, based on ($11.1) million net loss available to common stockholders and 32.6 million basic and diluted weighted average common shares outstanding.

 

Non-GAAP Net Income, Adjusted EBITDA and Free Cash Flow

 

•

Non-GAAP net income was $2.0 million compared to ($6.7) million in the first quarter of 2020. Non-GAAP net income per share was $0.01 based on $0.4 million net income available to common stockholders and 34.4 million fully diluted weighted average common shares outstanding, compared to ($0.21) in the first quarter of 2020, based ($6.7) million net loss available to common stockholders and 32.6 million basic and fully diluted weighted average common shares outstanding.

 

•

Adjusted EBITDA was $14.8 million, compared to $4.1 million in the first quarter of 2020.

 

•

Free cash flow was $8.3 million, compared to ($11.0) million in the first quarter of 2020.

See important disclosures about non-GAAP measures, and a reconciliation of them to GAAP, below.

Balance Sheet

 

•

Cash and cash equivalents and marketable securities at March 31, 2021 totaled $188.9 million, compared to $185.8 million at the end of the fourth quarter of 2020.  

 

•

The full $50.0 million line of credit remains available to the company.

Business Outlook

Based on information available as of May 4, 2021, Benefitfocus is providing guidance for the second quarter as indicated below.

Second Quarter 2021

 

•

Total revenue is expected to be in the range of $58 million to $60 million.

 

•

Adjusted EBITDA is expected to be in the range of $8 million to $10 million.

 

•

Non-GAAP net loss is expected to be between ($3.6) and ($1.6) million, or between ($0.16) and ($0.10) per share based on 33.0 million basic shares outstanding.

Full Year 2021

The company is reiterating guidance previously provided for Full Year 2021 as follows:

 

•

Total revenue is expected to be in the range of $254 million to $260 million.

 

•

Adjusted EBITDA is expected to be in the range of $44 million to $50 million.

 

 

 

•

Free cash flow is expected to be in the range of $20 million to $26 million.

Adjusted EBITDA and free cash flow guidance excludes the impact of restructuring and impairment charges.

Management has not reconciled forward-looking non-GAAP net loss, adjusted EBITDA or free cash flow to their most directly comparable GAAP measure of GAAP net loss or GAAP operating cash flows. This is because we cannot predict with reasonable certainty the ultimate outcome of the various necessary GAAP components of such reconciliations, including, for example, those related to compensation, acquisition transactions and integration, or others that may arise during the year, without unreasonable effort. These components and other factors could materially impact the amount of future directly comparable GAAP measures, which may differ significantly from their non-GAAP counterparts. See below for additional important disclosures regarding our non-GAAP financial measures.

Conference Call Details:

In conjunction with this announcement, Benefitfocus will host a conference call to discuss the company’s financial results and business outlook on Tuesday, May 4, 2021, at 5:00 p.m. ET. To access this call, dial (877) 407-9208 (domestic) or (201) 493-6784 (international). A live webcast of the conference call will be available on the Investor Relations page of the company’s website at http://investor.benefitfocus.com/. After the conference call, a replay will be available until May 11, 2021, and can be accessed by dialing (844) 512-2921 (domestic) or (412) 317-6671 (international) with passcode 13718530.

 

About Benefitfocus

Benefitfocus (NASDAQ: BNFT) unifies the entire benefits industry through innovative technology solutions that bring efficiency, cost savings and simplicity to employee benefits administration. Our powerful cloud-based software, data-driven insights and thoughtfully designed services help employers, insurance brokers, health plans and suppliers address the complexity of benefits enrollment and engagement, while bringing easier access to health, wealth and lifestyle products through a world-class benefits experience. Our mission is simple: to improve lives with benefits. 

 

Non-GAAP Financial Measures

The company uses certain non-GAAP financial measures in this release, including non-GAAP gross profit, operating income/loss, net loss/income, net loss/income per common share, adjusted EBITDA and free cash flow. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance or financial position that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. 

Non-GAAP gross profit, operating income/loss, net loss/income and net loss/income per common share exclude stock-based compensation expenses, amortization of acquisition-related intangible assets, transaction and acquisition-related costs expensed, restructuring charges, expense related to the impairment of goodwill, intangible assets and long-lived assets, gain or loss on extinguishment of debt, and costs not core to our business. We define adjusted EBITDA as net loss before net interest, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense, expense related to the impairment of goodwill, intangible assets and long-lived assets, transaction and acquisition-related costs expensed, restructuring charges, gain or loss on extinguishment of debt, and costs not core to our business. We define free cash flow as cash used in operating activities less capital expenditures, adjusted to eliminate restructuring charges. Please note that other companies might define their non-GAAP financial measures differently than we do.

Management presents these non-GAAP financial measures in this release because it considers them to be important supplemental measures of performance. Management uses these non-GAAP financial measures for planning purposes, including analysis of the company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management believes that these non-GAAP financial measures provide additional insight for analysts and investors in evaluating the company's financial and operational

 

performance. Management also intends to provide these non-GAAP financial measures as part of the company’s future earnings discussions and, therefore, their inclusion should provide consistency in the company’s financial reporting.

Non-GAAP financial measures have limitations as an analytical tool. Investors are encouraged to review the reconciliation of the non-GAAP measures to their most directly comparable GAAP measures provided in this release, including in the accompanying tables.

Safe Harbor Statement

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: volatility and uncertainty in the global economy and financial markets in light of the evolving COVID-19 pandemic; our continuing losses and need to achieve GAAP profitability; fluctuations in our financial results; our ability to maintain our culture, retain and motivate qualified personnel; the immature and volatile market for our products and services; risks related to changing healthcare and other applicable regulations; risks associated with acquisitions; cyber-security risks; the need to innovate and provide useful products and services; our ability to compete effectively; privacy, security and other risks associated with our business; and the other risk factors set forth from time to time in our SEC filings, copies of which are available free of charge within the Investor Relations section of the Benefitfocus website at http://investor.benefitfocus.com/sec-filings or upon request from our Investor Relations Department. Benefitfocus assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

 

Source: Benefitfocus, Inc.


 

Benefitfocus, Inc.

Unaudited Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share data)

 

 

Three Months Ended

March 31,

 

 

 

 

2021

 

 

2020

 

Revenue

 

$

65,063

 

 

$

66,154

 

Cost of revenue(1)(2)(3)

 

 

28,593

 

 

 

33,912

 

Gross profit

 

 

36,470

 

 

 

32,242

 

Operating expenses:(1)(2)(3)

 

 

 

 

 

 

 

 

Sales and marketing

 

 

10,891

 

 

 

15,630

 

Research and development

 

 

10,832

 

 

 

11,768

 

General and administrative

 

 

9,862

 

 

 

10,515

 

Restructuring costs

 

 

1,400

 

 

 

–

 

Total operating expenses

 

 

32,985

 

 

 

37,913

 

Income (loss) from operations

 

 

3,485

 

 

 

(5,671

)

Other income (expense):

 

 

 

 

 

 

 

 

Interest income

 

 

57

 

 

 

426

 

Interest expense

 

 

(5,555

)

 

 

(5,891

)

Other (expense) income

 

 

(42

)

 

 

5

 

Total other expense, net

 

 

(5,540

)

 

 

(5,460

)

Loss before income taxes

 

 

(2,055

)

 

 

(11,131

)

Income tax expense

 

 

42

 

 

 

5

 

Net loss

 

 

(2,097

)

 

 

(11,136

)

Preferred dividends

 

 

(1,600

)

 

 

–

 

Net loss available to common stockholders

 

$

(3,697

)

 

$

(11,136

)

Comprehensive loss

 

$

(2,097

)

 

$

(11,136

)

 

 

 

 

 

 

 

 

 

Net loss per common share:

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.11

)

 

$

(0.34

)

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

Basic and diluted

 

 

32,490,811

 

 

 

32,638,805

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Stock-based compensation included in above line items:

 

 

 

 

 

 

 

 

Cost of revenue

 

$

326

 

 

$

667

 

Sales and marketing

 

 

580

 

 

 

880

 

Research and development

 

 

118

 

 

 

342

 

General and administrative

 

 

499

 

 

 

1,788

 

 

 

 

 

 

 

 

 

 

(2) Amortization of acquired intangible assets included in above line items:

 

 

 

 

 

 

 

 

Cost of revenue

 

$

337

 

 

$

317

 

Sales and marketing

 

 

76

 

 

 

91

 

Research and development

 

 

113

 

 

 

109

 

General and administrative

 

 

42

 

 

 

52

 

 

 

 

 

 

 

 

 

 

(3) Transaction and acquisition-related costs expensed included in above line items:

 

 

 

 

 

 

 

 

General and administrative

 

$

154

 

 

$

192

 

 

 


 

Benefitfocus, Inc.

Unaudited Consolidated Balance Sheets

(in thousands, except share and per share data)

 

 

As of

March 31,

2021

 

 

As of

December 31,

2020

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

94,046

 

 

$

90,706

 

Marketable securities

 

 

94,822

 

 

 

95,085

 

Accounts receivable, net

 

 

24,495

 

 

 

22,240

 

Contract, prepaid and other current assets

 

 

20,784

 

 

 

21,354

 

Total current assets

 

 

234,147

 

 

 

229,385

 

Property and equipment, net

 

 

27,981

 

 

 

29,701

 

Financing lease right-of-use assets

 

 

66,399

 

 

 

68,670

 

Operating lease right-of-use assets

 

 

1,047

 

 

 

1,107

 

Intangible assets, net

 

 

9,825

 

 

 

10,393

 

Goodwill

 

 

12,857

 

 

 

12,857

 

Deferred contract costs and other non-current assets

 

 

9,438

 

 

 

10,259

 

Total assets

 

$

361,694

 

 

$

362,372

 

Liabilities and stockholders' deficit

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

6,616

 

 

$

2,160

 

Accrued expenses

 

 

7,603

 

 

 

6,262

 

Accrued compensation and benefits

 

 

11,921

 

 

 

19,129

 

Deferred revenue, current portion

 

 

28,228

 

 

 

27,782

 

Lease liabilities and financing obligations, current portion

 

 

6,352

 

 

 

5,959

 

Total current liabilities

 

 

60,720

 

 

 

61,292

 

Deferred revenue, net of current portion

 

 

4,402

 

 

 

4,422

 

Convertible senior notes

 

 

187,176

 

 

 

184,308

 

Lease liabilities and financing obligations, net current portion

 

 

78,315

 

 

 

79,282

 

Other non-current liabilities

 

 

2,502

 

 

 

2,470

 

Total liabilities

 

 

333,115

 

 

 

331,774

 

Commitments and contingencies

 

 

 

 

 

 

 

 

Redeemable preferred stock:

 

 

 

 

 

 

 

 

Series A preferred stock, par value $0.001, 5,000,000 shares

  authorized, 1,777,778 and 1,777,778 shares issued and outstanding

  at March 31, 2021 and December 31, 2020, respectively,

  liquidation preference $45 per share as of March 31, 2021 and December 31, 2020, respectively

 

 

79,193

 

 

 

79,193

 

Stockholders' deficit:

 

 

 

 

 

 

 

 

Common stock, par value $0.001, 50,000,000 shares authorized,

   32,516,170 and 32,327,439 shares issued and outstanding

   at March 31, 2021 and December 31, 2020, respectively

 

 

33

 

 

 

32

 

Additional paid-in capital

 

 

427,508

 

 

 

427,431

 

Accumulated deficit

 

 

(478,155

)

 

 

(476,058

)

Total stockholders' deficit

 

 

(50,614

)

 

 

(48,595

)

Total liabilities, redeemable preferred stock and stockholders' deficit

 

$

361,694

 

 

$

362,372

 

 

 


 

Benefitfocus, Inc.

Unaudited Consolidated Statements of Cash Flows

(in thousands)

 

 

Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

Net loss

 

$

(2,097

)

 

$

(11,136

)

Adjustments to reconcile net loss to net cash and cash

   equivalents used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

6,353

 

 

 

5,884

 

Stock-based compensation expense

 

 

1,523

 

 

 

3,677

 

Accretion of interest on convertible senior notes

 

 

2,868

 

 

 

2,924

 

Interest accrual on finance lease liabilities

 

 

1,879

 

 

 

23

 

Rent expense less than payments

 

 

(13

)

 

 

(9

)

Non-cash interest income for short-term investments

 

 

227

 

 

 

–

 

Loss on disposal or impairment of property and equipment

 

 

45

 

 

 

–

 

Provision for doubtful accounts

 

 

–

 

 

 

55

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

(2,256

)

 

 

189

 

Accrued interest on short-term investments

 

 

(136

)

 

 

–

 

Contract, prepaid and other current assets

 

 

463

 

 

 

252

 

Deferred costs and other non-current assets

 

 

823

 

 

 

557

 

Accounts payable and accrued expenses

 

 

5,835

 

 

 

(1,593

)

Accrued compensation and benefits

 

 

(7,208

)

 

 

(4,000

)

Deferred revenue

 

 

426

 

 

 

(3,969

)

Other non-current liabilities

 

 

32

 

 

 

(24

)

Net cash and cash equivalents provided by (used in) operating activities

 

 

8,764

 

 

 

(7,170

)

Cash flows from investing activities

 

 

 

 

 

 

 

 

Purchases of short term investments held to maturity

 

 

(22,329

)

 

 

–

 

Proceeds from short-term investments held to maturity

 

 

22,500

 

 

 

–

 

Purchases of property and equipment

 

 

(1,893

)

 

 

(3,821

)

Net cash and cash equivalents used in investing activities

 

 

(1,722

)

 

 

(3,821

)

Cash flows from financing activities

 

 

 

 

 

 

 

 

Draws on revolving line of credit

 

 

–

 

 

 

10,000

 

Payments of debt issuance costs

 

 

–

 

 

 

(154

)

Payments of preferred dividends

 

 

(1,600

)

 

 

–

 

Repurchase of common stock

 

 

–

 

 

 

(9,383

)

Proceeds from exercises of stock options and ESPP

 

 

155

 

 

 

73

 

Payments on financing obligations

 

 

(223

)

 

 

(207

)

Payments of principal on finance lease liabilities

 

 

(2,034

)

 

 

(5,600

)

Net cash and cash equivalents used in financing activities

 

 

(3,702

)

 

 

(5,271

)

Net increase (decrease) in cash and cash equivalents

 

 

3,340

 

 

 

(16,262

)

Cash and cash equivalents, beginning of period

 

 

90,706

 

 

 

130,976

 

Cash and cash equivalents, end of period

 

$

94,046

 

 

$

114,714

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of non-cash investing and financing activities

 

 

 

 

 

 

 

 

Property and equipment purchases in accounts payable and accrued expenses

 

$

88

 

 

$

31

 

 

 


 

 

Benefitfocus, Inc.

Unaudited Reconciliation of GAAP to Non-GAAP Measures

(in thousands, except share and per share data)

 

 

Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Reconciliation from Gross Profit to Non-GAAP Gross Profit:

 

 

 

 

 

 

 

 

Gross profit

 

$

36,470

 

 

$

32,242

 

Amortization of acquired intangible assets

 

 

337

 

 

 

317

 

Stock-based compensation expense

 

 

326

 

 

 

667

 

Total net adjustments

 

 

663

 

 

 

984

 

Non-GAAP gross profit

 

$

37,133

 

 

$

33,226

 

 

 

 

 

 

 

 

 

 

Reconciliation from Operating Income (Loss) to Non-GAAP Operating Income (Loss):

 

 

 

 

 

 

 

 

Operating income (loss)

 

$

3,485

 

 

$

(5,671

)

Amortization of acquired intangible assets

 

 

568

 

 

 

569

 

Stock-based compensation expense

 

 

1,523

 

 

 

3,677

 

Transaction and acquisition-related costs expensed

 

 

154

 

 

 

192

 

Costs not core to our business

 

 

1,881

 

 

 

—

 

Total net adjustments

 

 

4,126

 

 

 

4,438

 

Non-GAAP operating income (loss)

 

$

7,611

 

 

$

(1,233

)

 

 

 

 

 

 

 

 

 

Reconciliation from Net Loss to Adjusted EBITDA:

 

 

 

 

 

 

 

 

Net loss

 

$

(2,097

)

 

$

(11,136

)

Depreciation

 

 

3,623

 

 

 

3,796

 

Amortization of software development costs

 

 

2,162

 

 

 

1,519

 

Amortization of acquired intangible assets

 

 

568

 

 

 

569

 

Interest income

 

 

(57

)

 

 

(426

)

Interest expense

 

 

5,555

 

 

 

5,891

 

Income tax expense

 

 

42

 

 

 

5

 

Stock-based compensation expense

 

 

1,523

 

 

 

3,677

 

Transaction and acquisition-related costs expensed

 

 

154

 

 

 

192

 

Restructuring costs

 

 

1,400

 

 

 

—

 

Costs not core to our business

 

 

1,881

 

 

 

—

 

Total net adjustments

 

 

16,851

 

 

 

15,223

 

Adjusted EBITDA

 

$

14,754

 

 

$

4,087

 

 

 

 

 

 

 

 

 

 

Reconciliation from Net Loss to Non-GAAP Net Income (Loss):

 

 

 

 

 

 

 

 

Net loss

 

$

(2,097

)

 

$

(11,136

)

Amortization of acquired intangible assets

 

 

568

 

 

 

569

 

Stock-based compensation expense

 

 

1,523

 

 

 

3,677

 

Transaction and acquisition-related costs expensed

 

 

154

 

 

 

192

 

Costs not core to our business

 

 

1,881

 

 

 

—

 

Total net adjustments

 

 

4,126

 

 

 

4,438

 

Non-GAAP net income (loss)

 

$

2,029

 

 

$

(6,698

)

 

 

 

 

 

 

 

 

 

Calculation of Non-GAAP Earnings Per Share:

 

 

 

 

 

 

 

 

Non-GAAP net income (loss)

 

$

2,029

 

 

$

(6,698

)

Preferred dividends

 

 

(1,600

)

 

 

—

 

Undistributed earnings allocated to preferred stockholders

 

 

(61

)

 

 

—

 

Non-GAAP net income (loss) available to common stockholders

 

$

368

 

 

$

(6,698

)

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding - basic

 

 

32,490,811

 

 

 

32,638,805

 

Weighted average shares outstanding - diluted

 

 

32,490,811

 

 

 

32,638,805

 

Shares used in computing non-GAAP net income (loss) per share - basic

 

 

32,490,811

 

 

 

32,638,805

 

Shares used in computing non-GAAP net income (loss) per share - diluted

 

 

34,352,380

 

 

 

32,638,805

 

Non-GAAP net income (loss) per common share - basic

 

$

0.01

 

 

$

(0.21

)

Non-GAAP net income (loss) per common share - diluted

 

$

0.01

 

 

$

(0.21

)

 

 

 

 

 

 

 

 

 

Reconciliation of Cash Flows from Operations to Free Cash Flow:

 

 

 

 

 

 

 

 

Net cash and cash equivalents provided by (used in) operating activities

 

$

8,764

 

 

$

(7,170

)

 

Purchases of property and equipment

 

 

(1,893

)

 

 

(3,821

)

Cash paid for restructuring costs

 

 

1,379

 

 

 

—

 

Total net adjustments

 

 

(514

)

 

 

(3,821

)

Free Cash Flow

 

$

8,250

 

 

$

(10,991

)

 

 GRAPHIC 3 gs2oz4d3unuq000001.jpg GRAPHIC begin 644 gs2oz4d3unuq000001.jpg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end EX-101.SCH 4 bnft-20210504.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 5 bnft-20210504_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 6 bnft-20210504_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 bnft-8k_20210504_htm.xml IDEA: XBRL DOCUMENT 0001576169 2021-05-04 2021-05-04 false 0001576169 8-K 2021-05-04 BENEFITFOCUS, INC. DE 001-36061 46-2346314 100 Benefitfocus Way Charleston SC 29492 843 849-7476 false false false false Common Stock, $0.001 Par Value BNFT NASDAQ false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Document and Entity Information
May 04, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 04, 2021
Entity Registrant Name BENEFITFOCUS, INC.
Entity Central Index Key 0001576169
Entity Emerging Growth Company false
Entity File Number 001-36061
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 46-2346314
Entity Address, Address Line One 100 Benefitfocus Way
Entity Address, City or Town Charleston
Entity Address, State or Province SC
Entity Address, Postal Zip Code 29492
City Area Code 843
Local Phone Number 849-7476
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 Par Value
Trading Symbol BNFT
Security Exchange Name NASDAQ
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports bnft-8k_20210504.htm bnft-20210504.xsd bnft-20210504_lab.xml bnft-20210504_pre.xml bnft-ex991_21.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bnft-8k_20210504.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "bnft-8k_20210504.htm" ] }, "labelLink": { "local": [ "bnft-20210504_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "bnft-20210504_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "bnft-20210504.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "bnft", "nsuri": "http://www.benefitfocus.com/20210504", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "bnft-8k_20210504.htm", "contextRef": "C_0001576169_20210504_20210504", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "bnft-8k_20210504.htm", "contextRef": "C_0001576169_20210504_20210504", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.benefitfocus.com/20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001564590-21-023357-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-023357-xbrl.zip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end